A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer

By Yamada Yasuhide   Kiyota Naomi   Fuse Nozomu   Kato Ken   Minami Hironobu   Hashizume Kensei   Kuroki Yoshihiro   Ito Yuichiro   Ohtsu Atsushi  

Gastric Cancer, Vol. 17, Iss. 1, 2014-01 ,pp. : 161-172

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer

By Takahari Daisuke   Shimada Yasuhiro   Takeshita Shigeyuki   Nishitani Hitoshi   Takashima Atsuo   Okita Natsuko   Hirashima Yoshinori   Kato Ken   Hamaguchi Tetsuya   Yamada Yasuhide   Shirao Kuniaki  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 186-190

Springer Publishing Company

Access to resources Recommend Favorite

Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer

By Choi In   Lee Keun-Wook   Kim Ki   Kim Yu   Kim Jee   Lee Jong  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 992-997

Humana Press, Inc

Access to resources Recommend Favorite

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer

By Moriwaki Toshikazu   Hirai Shinji   Hironaka Shuichi   Amagai Kenji   Soeda Atsuko   Sato Mikio   Nihei Takeshi   Hirose Mitsuaki   Matsuda Kenji   Ohkawara Atsushi   Yamaguchi Taketo   Ozeki Mitsuharu   Mamiya Takashi   Murashita Tetsuya   Hyodo Ichinosuke  

Gastric Cancer, Vol. 17, Iss. 2, 2014-04 ,pp. : 354-361

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite